Press Release

FOR IMMEDIATE RELEASE

January 22, 2020

 

Provell Pharmaceuticals, LLC Announces the launch of MyOldMeds.com as a member of the Pharmaceutical Product Stewardship Work Group (PPSWG).

 

The Pharmaceutical Product Stewardship Work Group (PPSWG) has re-launched a website to provide information about securely storing and disposing of unwanted, unused, or expired medicines from households, information about following instructions provided with your medicines, and a Kiosk Site Locator.

 

PPSWG has updated the MyOldMeds.com website to assist in improving the understanding of appropriate pharmaceutical product storage and disposal options for households.

 

The MyOldMeds.com website addresses the following important functions and provides instructions on each:

 

1. Adhering to instructions provided with your medicines, including labeling information and Medication Guides;

2. Securely storing medicine; and

3. Disposing of unwanted, unused, or expired medicines from households.

 

The website also features a Kiosk Site Locator, providing a comprehensive map of kiosk sites throughout all fifty states.

About PPSWG

The Pharmaceutical Product Stewardship Work Group (PPSWG), a US-based non-profit membership association comprised of producers of pharmaceutical products (including branded and generic prescription and over-the-counter pharmaceutical products), re-launched the MyOldMeds.com website on January 22, 2020.

https://www.med-project.org/

 

Press Contact:

Stanton J. Barrett, VP Membership & Communications

PPSWG

sbarrett@ppswg.org

202-580-6298

About Provell Pharmaceuticals, LLC

 

Located in Honey Brook, PA, Provell is a small, private healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Their goal is to provide unique and innovative delivery of pharmaceutical products to help enhance drug quality, increase patient adherence, resulting in improved patient outcomes.

 

Provell entered an exclusive marketing and distribution agreement with Merck KGaA Darmstadt, Germany on September 28, 2013 for the U.S. Market.

 

Euthyrox® (levothyroxine sodium) is a registered trademark of Merck KGaA Darmstadt, Germany.

 

No use of any Provell Pharmaceuticals, Euthyrox®, and Merck KGaA Darmstadt trademark, trade name, or trade dress may be made without the prior written authorization of Provell Pharmaceuticals, LLC and Merck KGaA, Darmstadt, Germany.

 

For More Information:

 

info@provellpharma.com

dailymed.nlm.nih.gov

FOR IMMEDIATE RELEASE 08:30 AM EST

September 14th, 2018

 

Provell Pharmaceuticals Announces the FDA Approval of Euthyrox® (levothyroxine sodium) for the U.S. Market.

 

Honey Brook, PA — Provell Pharmaceuticals, LLC (Provell) announced today that the FDA has granted approval for Euthyrox® (levothyroxine sodium).  Provell is also pleased to share that according to the FDA, it was determined that Euthyrox® (levothyroxine sodium) tablets to be bioequivalent and therapeutically equivalent to Synthroid® (levothyroxine sodium) tablets.  The FDA Orange Book is updated to reflect the bioequivalence and therapeutic interchangeability within the AB2 class.  Please click here to access this report.

 

“The FDA approval of Euthyrox for the U.S. thyroid hormone replacement market is the beginning of Provell Pharmaceuticals’ goal to bring a valuable alternative product to this very common medical condition, hypothyroidism.  We are very excited about our market entry in early 2019.”
–Jim Small, CEO Provell Pharmaceuticals, LLC

 

About Provell Pharmaceuticals, LLC

 

Located in Honey Brook, PA, Provell is a small, private healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Their goal is to provide unique and innovative delivery of pharmaceutical products to help enhance drug quality, increase patient adherence, resulting in improved patient outcomes.

 

Provell entered an exclusive marketing and distribution agreement with Merck KGaA Darmstadt, Germany on September 28, 2013 for the U.S. Market.

 

Euthyrox® (levothyroxine sodium) is a registered trademark of Merck KGaA Darmstadt, Germany.

 

No use of any Provell Pharmaceuticals, Euthyrox®, and Merck KGaA Darmstadt trademark, trade name, or trade dress may be made without the prior written authorization of Provell Pharmaceuticals, LLC and Merck KGaA, Darmstadt, Germany.

 

For More Information:

 

info@provellpharma.com

dailymed.nlm.nih.gov

1801 Horseshoe Pike - Suite 1, Honey Brook, PA 19344, USA 
101 Hudson Street - 21st Floor - Suite 2100, Jersey City, NJ 07302 USA

(Main) 610.942.8970  (Fax) 610.942.8973

info@provellpharma.com

LinkedIn Logo Image.png

©2020 by Provell Pharmaceuticals, LLC
No use of any Provell Pharmaceuticals trademark, trade name, or trade dress in this site may be made without the prior written authorization of Provell Pharmaceuticals, LLC, except to identify the product or services of the company.

Provell Horizontal Logo.v2.2017.PNG